体外診断（IVD）の世界市場予測（～2021）：製品別、技術別（イムノアッセイ、臨床化学、分子診断、血液学）、用途別...市場調査レポートについてご紹介

1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 24)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 31)

4 Premium Insights (Page No. – 40)
4.1 In Vitro Diagnostics (IVD): Market Overview
4.2 Asia-Pacific: In Vitro Diagnostics Market, By Products & Services
4.3 Geographic Snapshot of the In Vitro Diagnostics Market
4.4 Geographic Mix: In Vitro Diagnostics Market
4.5 In Vitro Diagnostics Market: Developing vs Developed Markets

5 Market Overview (Page No. – 45)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Rising Incidence of Chronic Lifestyle Diseases
5.2.1.2 Increasing Adoption of Point-Of-Care Testing
5.2.1.3 Growing Awareness of Personalized Medicine
5.2.1.4 Growth in the Number of Private Diagnostic Centers
5.2.2 Market Restraints
5.2.2.1 Inadequate Reimbursement
5.2.2.2 Rising Healthcare Costs and Low Budgets
5.2.3 Market Opportunities
5.2.3.1 Introduction of A New Range of Condition-Specific Markers and Tests With Advances in Genomics and Proteomics
5.2.3.2 Emerging Economies With Increasing Investments
5.2.3.3 Growing Significance of Companion Diagnostics
5.2.4 Market Challenges
5.2.4.1 Stringent Regulatory Framework
5.2.4.2 Operational Barriers for the Use of Diagnostic Tests

6 Industry Insights (Page No. – 56)
6.1 Introduction
6.2 Industry Trends
6.2.1 Automation of Clinical Laboratory Techniques
6.2.2 Microfluidics-Based Poc and Loc Diagnostic Devices for Laboratory Testing
6.2.3 Rise in Reagent Rental Agreements
6.3 Regulatory Overview
6.3.1 North America
6.3.1.1 U.S.
6.3.1.2 Canada
6.3.2 Europe
6.3.3 Asia-Pacific
6.3.3.1 Japan
6.3.3.2 China
6.3.3.3 India

7 Global In Vitro Diagnostics Market, By Product & Service (Page No. – 65)
7.1 Introduction
7.2 Reagents & Kits
7.3 Instruments
7.4 Data Management Software
7.5 Services

8 Global In Vitro Diagnostics Market, By Technology (Page No. – 74)
8.1 Introduction
8.2 Immunochemistry/Immunoassays
8.2.1 Enzyme-Linked Immunosorbent Assay (ELISA)
8.2.1.1 Chemiluminescence Immunoassays (CLIAS)
8.2.1.2 Fluorescence Immunoassays (FIAS)
8.2.1.3 Colorimetric Immunoassays (CIS)
8.2.2 Radioimmunoassay (RIA)
8.2.3 Rapid Tests
8.2.4 Western Blot
8.2.5 Enzyme-Linked Immunospot (Elispot) Assay
8.3 Clinical Chemistry
8.3.1 Basic Metabolic Panel
8.3.2 Electrolyte Panel
8.3.3 Liver Panel
8.3.4 Lipid Profile
8.3.5 Renal Profile
8.3.6 Thyroid Function Panel
8.3.7 Specialty Chemical Tests
8.4 Molecular Diagnostics (MDX)
8.4.1 Polymerase Chain Reaction (PCR)
8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.3 Microarray
8.4.4 Hybridization
8.4.5 Dna Sequencing & Next-Generation Sequencing
8.4.6 Other MDX Technologies
8.5 Clinical Microbiology
8.6 Hematology
8.7 Coagulation and Hemostasis
8.8 Other IVD Technologies

9 Global In Vitro Diagnostics Market, By Application (Page No. – 114)
9.1 Introduction
9.2 Diabetes
9.3 Infectious Diseases
9.4 Oncology/Cancer
9.5 Cardiology
9.6 Nephrology
9.7 Autoimmune Diseases
9.8 Drug Testing/Pharmacogenomics
9.9 HIV/Aids
9.10 Other Applications

10 Global In Vitro Diagnostics Market, By End User (Page No. – 132)
10.1 Introduction
10.2 Hospitals
10.3 Laboratories
10.4 Point-Of-Care Testing
10.5 Patient Self-Testing
10.6 Academic Institutes
10.7 Other End Users

11 Global In Vitro Diagnostics Market, By Region (Page No. – 142)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Russia
11.3.7 Rest of Europe (RoE)
11.4 Asia-Pacific (APAC)
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia-Pacific (RoAPAC)
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America (ROLA)
11.6 Middle East and Africa

12 Competitive Landscape (Page No. – 207)
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Situation and Trends
12.4 New Product Launches
12.5 Agreements, Partnerships, and Collaborations
12.6 Acquisitions
12.7 Expansions
12.8 Other Strategies

13 Company Profiles (Page No. – 215)
(Overview, Products and Services, Financials, Strategy & Development)*
13.1 Introduction
13.2 ABBott Laboratories, Inc.
13.3 Becton, Dickinson and Company
13.4 Biomérieux SA
13.5 Bio-Rad Laboratories, Inc.
13.6 Danaher Corporation
13.7 Johnson & Johnson
13.8 Roche Diagnostics
13.9 Siemens AG
13.10 Sysmex Corporation
13.11 Thermo Fisher Scientific, Inc.
13.12 Ortho-Clinical Diagnostics, Inc.
13.13 Qiagen N.V.
13.14 Diasorin S.P.A.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. – 275)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Other Developments
14.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.5 Introducing RT: Real-Time Market Intelligence
14.6 Available Customizations
14.7 Related Reports
14.8 Author Details